期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 15, 期 11, 页码 1026-1032出版社
ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2009.02856.x
关键词
Aetiology; community-acquired pneumonia; complication; C-reactive protein; disease severity
资金
- Maud Kuistila Foundation
- Turku University Central Hospital Research Fund
P>Previous studies on the usefulness of C-reactive protein (CRP) in patients with community-acquired pneumonia (CAP) have yielded somewhat inconsistent results. Our aim was to assess the value of CRP in estimating the severity and complications of CAP. CRP levels during the first 5 days of hospitalization were measured in 384 adult patients with CAP, and the data were evaluated using comprehensive statistical analyses. Significantly higher CRP levels on admission were detected in Pneumonia Severity Index (PSI) classes III-V than in classes I and II (p < 0.001). An increment of 50 mg/L CRP on admission was associated with a 1.22-fold odds for a patient to be in PSI classes III-V as compared with classes I and II (OR 1.22, 95% CI 1.11-1.34; p < 0.001). CRP levels were significantly higher in bacteraemic pneumonia than in non-bacteraemic pneumonia (p < 0.001). An increment of 50 mg/L CRP was associated with a 1.67-fold odds for a patient to be bacteraemic (OR 1.67, 95% CI 1.46-1.92; p < 0.001). CRP levels > 100 mg/L on day 4 after the admission were significantly associated with complications (p < 0.01). There was a trend for an association between the level of CRP on admission and the time to reach clinical stability (p < 0.01). In conclusion, CRP may be valuable for revealing the development of complications in CAP. It may also be useful to assess the disease severity, thus being complementary to the assessment of the PSI. In our patients, high CRP levels were associated with a failure to reach clinical stability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据